08.03.2022 - 10.03.2022Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 15:30
Temas de la conferencia Following significant progress in obtaining structural insights from transcription factor-DNA (TF-DNA) complexes using techniques like cryo-electron microscopy, Biotech is continuing to pour investment into developing therapeutic interventions to address increased expression of specific transcription factor associated oncogenes and oncogene amplification in cancer.
Organizador profesional (PCO) Hanson Wade
Observaciones Speakers: Alex Federation, Co-Founder and Chief Executive Officer, Talus Bio, Alon Goren, Assistant Professor, University of California San Diego, Ben Amidon, Senior Director, Ikena Oncology and more.